Bonner Michael 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Nov 24, 2017
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2017-11-22$7.81/sh+250$1,953→ 15,697 total
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Nov 24, 2017
Common Stock